Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells.
Saved in:
| Title: | Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells. |
|---|---|
| Authors: | Pratt SE; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. Pratt_Susan@lilly.com, Durland-Busbice S, Shepard RL, Heinz-Taheny K, Iversen PW, Dantzig AH |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Mar 01; Vol. 19 (5), pp. 1159-68. Date of Electronic Publication: 2013 Jan 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
